Melody Noel Brown

Array ( [id] => 13209565 [patent_doc_number] => 10119144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Polycomb-associated non-coding RNAs [patent_app_type] => utility [patent_app_number] => 15/050273 [patent_app_country] => US [patent_app_date] => 2016-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 68 [patent_no_of_words] => 55390 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822402 [patent_doc_number] => 20160168566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'Methods and Compositions using miR-3151 in the Diagnosis and Treatment of Thyroid Cancer' [patent_app_type] => utility [patent_app_number] => 15/042468 [patent_app_country] => US [patent_app_date] => 2016-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 29709 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15042468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12178956 [patent_doc_number] => 20180037892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-08 [patent_title] => 'EPCAM APTAMERS AND CONJUGATES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/550671 [patent_app_country] => US [patent_app_date] => 2016-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21713 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11025433 [patent_doc_number] => 20160222388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'CHEMICAL INHIBITION OF FERROCHELATASE AS AN ANTIANGIOGENIC THERAPY' [patent_app_type] => utility [patent_app_number] => 15/009339 [patent_app_country] => US [patent_app_date] => 2016-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8314 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15009339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11047796 [patent_doc_number] => 20160244753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/995432 [patent_app_country] => US [patent_app_date] => 2016-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 44182 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14995432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11003855 [patent_doc_number] => 20160200804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING ANAPLASTIC THYROID CANCER' [patent_app_type] => utility [patent_app_number] => 14/992674 [patent_app_country] => US [patent_app_date] => 2016-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24351 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14992674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11722357 [patent_doc_number] => 09695206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-04 [patent_title] => 'RNA interference agents for P21 gene modulation' [patent_app_type] => utility [patent_app_number] => 14/979571 [patent_app_country] => US [patent_app_date] => 2015-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8577 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14979571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13703273 [patent_doc_number] => 20170362591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => NON-AGGREGATING IMMUNOSTIMULATORY OLIGONUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 15/539617 [patent_app_country] => US [patent_app_date] => 2015-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20418 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17513891 [patent_doc_number] => 11293024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-05 [patent_title] => Antisense antibacterial compounds and methods [patent_app_type] => utility [patent_app_number] => 15/540387 [patent_app_country] => US [patent_app_date] => 2015-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 18 [patent_no_of_words] => 20260 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15540387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10814056 [patent_doc_number] => 20160160216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'TTV MIRNA SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER AND AS A TARGET FOR CANCER TREATMENT AND PREVENTION' [patent_app_type] => utility [patent_app_number] => 14/966110 [patent_app_country] => US [patent_app_date] => 2015-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14961 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14966110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10814056 [patent_doc_number] => 20160160216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'TTV MIRNA SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER AND AS A TARGET FOR CANCER TREATMENT AND PREVENTION' [patent_app_type] => utility [patent_app_number] => 14/966110 [patent_app_country] => US [patent_app_date] => 2015-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14961 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14966110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12980608 [patent_doc_number] => 20170342411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => Methods and Pharmaceutical Compositions for Treating Human Immunodeficiency Virus Type 1 (HIV-1) Infections [patent_app_type] => utility [patent_app_number] => 15/534321 [patent_app_country] => US [patent_app_date] => 2015-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8365 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15534321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10737581 [patent_doc_number] => 20160083729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'PHASE CHANGING FORMULATIONS OF NUCLEIC ACID PAYLOADS' [patent_app_type] => utility [patent_app_number] => 14/957073 [patent_app_country] => US [patent_app_date] => 2015-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 41632 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14957073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10722719 [patent_doc_number] => 20160068863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'METHODS FOR HEART REGENERATION' [patent_app_type] => utility [patent_app_number] => 14/946644 [patent_app_country] => US [patent_app_date] => 2015-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 31929 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14946644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10805249 [patent_doc_number] => 20160151406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'COMBINATION CANCER THERAPY WITH C-MET INHIBITORS AND SYNTHETIC OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 14/946456 [patent_app_country] => US [patent_app_date] => 2015-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20148 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14946456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15666879 [patent_doc_number] => 10597660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-24 [patent_title] => Compositions and methods of treating amyotrophic lateral sclerosis (ALS) [patent_app_type] => utility [patent_app_number] => 15/526690 [patent_app_country] => US [patent_app_date] => 2015-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 36322 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15526690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12031117 [patent_doc_number] => 20170321216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'MODULATION OF AGPAT5 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 15/526471 [patent_app_country] => US [patent_app_date] => 2015-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36886 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15526471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10989230 [patent_doc_number] => 20160186172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'Compositions and methods for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression' [patent_app_type] => utility [patent_app_number] => 14/939985 [patent_app_country] => US [patent_app_date] => 2015-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 71573 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14939985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12058979 [patent_doc_number] => 20170335324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'METHODS FOR TREATING NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 15/525396 [patent_app_country] => US [patent_app_date] => 2015-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 28346 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10750750 [patent_doc_number] => 20160096900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'QSOX1 as an Anti-Neoplastic Drug Target' [patent_app_type] => utility [patent_app_number] => 14/934644 [patent_app_country] => US [patent_app_date] => 2015-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 22628 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14934644 [rel_patent_id] =>[rel_patent_doc_number] =>)